Headache
Headache, licence 80073261: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- 9315-4466 Quebec Inc
- NPN or DIN-HM
- 80073261
- Status
- Inactive licence
- Licence date
- 26 October 2016
- Revision date
- Not provided
- Form
- Huile
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lavandula angustifolia Source : Sommité en fleurs (herbe) | 5.0 % | Not calculated |
Non-medicinal ingredients
Huile essentielle de feuilles de Picea mariana, Huile essentielle de pelure de citron, Huile de coco fractionnée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | Not specified | Not specified |
Uses authorised in Canada
Used in aromatherapy as a nervine/calmative. Used in aromatherapy to help relieve joint/muscle pain associated with sprain/strain/rheumatoid arthritis. Used in aromatherapy to help relieve headache. Used in aromatherapy to help relieve colds/cough.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
If you experience nausea, dizziness, headache or an allergic reaction, discontinue use.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. If you have broken, irritated, or sensitive skin, do not use this product.
- Précautions et mises en garde
Keep out of reach of children. If accidental ingestion occurs, seek urgent medical attention or contact a Poison Control Center. If symptoms persist or worsen, consult a health care practitioner. If you have epilepsy or asthma, consult a health care practitioner prior to use Do not expose the applied area(s) to the sun for 24 to 48 hours after application.
Source
Official Health Canada record, licence 80073261
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.